These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8276939)

  • 41. Chronic stress and memory: implication of the central cholinergic system.
    Zerbib R; Laborit H
    Pharmacol Biochem Behav; 1990 Aug; 36(4):897-900. PubMed ID: 2217520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anterograde memory for visuospatial arrays.
    Meador KJ; Meador AS; Loring DW; Lee GP; Martin RC
    Int J Neurosci; 1990 Mar; 51(1-2):1-8. PubMed ID: 2265902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholinergic control of cognitive resources.
    Warburton DM; Rusted JM
    Neuropsychobiology; 1993; 28(1-2):43-6. PubMed ID: 8255409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scopolamine impairs spatial maze performance in rats.
    Stevens R
    Physiol Behav; 1981 Aug; 27(2):385-6. PubMed ID: 7301971
    [No Abstract]   [Full Text] [Related]  

  • 45. The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis.
    Dunne MP; Hartley LR
    Acta Psychol (Amst); 1985 Mar; 58(3):205-17. PubMed ID: 3993408
    [No Abstract]   [Full Text] [Related]  

  • 46. Cerebellar information processing and visuospatial functions.
    Molinari M; Leggio MG
    Cerebellum; 2007; 6(3):214-20. PubMed ID: 17786817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of heat, cold, and work on the central actions of scopolamine.
    Safer DJ
    Clin Pharmacol Ther; 1970; 11(1):60-7. PubMed ID: 5410896
    [No Abstract]   [Full Text] [Related]  

  • 48. Partial reversal of anticholinergic amnesia by choline chloride.
    Mohs RC; Davis KL; Levy MI
    Life Sci; 1981 Sep; 29(13):1317-23. PubMed ID: 7289784
    [No Abstract]   [Full Text] [Related]  

  • 49. Odd-even short forms of the Judgment of Line Orientation Test.
    Venderploeg RD; LaLone LV; Greblo P; Schinka JA
    Appl Neuropsychol; 1997; 4(4):244-6. PubMed ID: 16318474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Side effects of scopolamine administration.
    Serby M; Corwin J; Jordan B; Novatt A; Rotrosen J
    Am J Psychiatry; 1984 Aug; 141(8):1010. PubMed ID: 6465355
    [No Abstract]   [Full Text] [Related]  

  • 51. An interpretation of some conflicting evidence regarding the effects of scopolamine upon vigilance.
    Dunne MP
    Psychopharmacology (Berl); 1985; 87(1):126. PubMed ID: 3933032
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of an
    Lopresti AL; Smith SJ; Majeed M; Drummond PD
    Front Aging Neurosci; 2021; 13():728360. PubMed ID: 34531736
    [No Abstract]   [Full Text] [Related]  

  • 53. Cognitive function after electroconvulsive therapy for depression: relationship to clinical response.
    Anderson IM; McAllister-Williams RH; Downey D; Elliott R; Loo C
    Psychol Med; 2021 Jul; 51(10):1647-1656. PubMed ID: 32102725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physical Activity Throughout the Adult Life Span and Domain-Specific Cognitive Function in Old Age: A Systematic Review of Cross-Sectional and Longitudinal Data.
    Engeroff T; Ingmann T; Banzer W
    Sports Med; 2018 Jun; 48(6):1405-1436. PubMed ID: 29667159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Attention Network Test-Interaction (ANT-I): reliability and validity in healthy older adults.
    Ishigami Y; Eskes GA; Tyndall AV; Longman RS; Drogos LL; Poulin MJ
    Exp Brain Res; 2016 Mar; 234(3):815-27. PubMed ID: 26645310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
    Trevithick L; McAllister-Williams RH; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Ellwell C; Hayden K; Holland F; Karim S; Lowe J; Loo C; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; Anderson IM
    BMC Psychiatry; 2015 Oct; 15():257. PubMed ID: 26489663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validity of a screening tool for detecting subtle cognitive impairment in the middle-aged and elderly.
    Bruce KM; Robinson SR; Smith JA; Yelland GW
    Clin Interv Aging; 2014; 9():2165-76. PubMed ID: 25540581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized controlled trial of brief and ultrabrief pulse right unilateral electroconvulsive therapy.
    Loo CK; Katalinic N; Smith DJ; Ingram A; Dowling N; Martin D; Addison K; Hadzi-Pavlovic D; Simpson B; Schweitzer I
    Int J Neuropsychopharmacol; 2014 Dec; 18(1):. PubMed ID: 25522389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Group cognitive remediation therapy for adult anorexia nervosa inpatients: first experiences.
    Zuchova S; Erler T; Papezova H
    Eat Weight Disord; 2013 Sep; 18(3):269-73. PubMed ID: 23765593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The brain-in-motion study: effect of a 6-month aerobic exercise intervention on cerebrovascular regulation and cognitive function in older adults.
    Tyndall AV; Davenport MH; Wilson BJ; Burek GM; Arsenault-Lapierre G; Haley E; Eskes GA; Friedenreich CM; Hill MD; Hogan DB; Longman RS; Anderson TJ; Leigh R; Smith EE; Poulin MJ
    BMC Geriatr; 2013 Feb; 13():21. PubMed ID: 23448504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.